• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

右美托咪定通过 MAPK 信号通路上调 miR-146a 表达减轻 H9C2 心肌细胞缺氧/复氧损伤。

Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.

机构信息

Department of Cardiology, The Second Affiliated Hospital of Air Force Military Medical University, Xi'an, China.

出版信息

Pharmacology. 2022;107(1-2):14-27. doi: 10.1159/000506814. Epub 2021 Oct 29.

DOI:10.1159/000506814
PMID:34718238
Abstract

INTRODUCTION AND OBJECTIVE

Dexmedetomidine (Dex) and a number of miRNAs contribute to ischemia/reperfusion injury. We aimed to explore the role of Dex and miR-146a on myocardial cells injured by hypoxia/reoxygenation (H/R).

METHOD

H9C2 cells were injured by H/R. Cell viability was tested using the cell counting kit-8. Lactate dehydrogenase (LDH) activity, superoxide dismutase (SOD) activity, and malondialdehyde (MDA) levels were determined using commercial kits. Flow cytometry was performed to determine apoptosis rate and reactive oxygen species (ROS) level. Protein and mRNA levels were assessed using Western blot and qPCR.

RESULTS

miR-146a expression and cell viability of H9C2 cells were downregulated under the circumstance of H/R injury. The tendency could be reversed by Dex, which could also upregulate SOD activity and decrease apoptosis, LDH activity, MDA, 78-kDa glucose-regulated protein (GRP78), and C/EBP homologous protein (CHOP) levels of H9C2 cells. GRP78, CHOP levels, and cell viability were negatively modulated by miR-146a. Dex elevated cell viability, catalase, MnSOD, and NAD(P)H dehydrogenase (NQO1) levels but suppressed apoptosis rate, GRP78, and CHOP levels by increasing miR-146a expression and downregulating ROS, phosphorylation of p38, and extracellular signal-regulated kinases 1/2 levels. By using SB203580 (SB), the p38 mitogen-activated protein kinase (MAPK) inhibitor, Dex or the inhibition of miR-146 upregulated cell viability but downregulated GRP78 and CHOP levels.

CONCLUSION

Dex might regulate miR-146a expression, which could further modulate the endoplasmic reticulum stress and oxidative stress and eventually affect the cell viability and apoptosis of myocardial cells injured by H/R via the MAPK signal pathway.

摘要

简介和目的

右美托咪定(Dex)和许多 miRNA 有助于缺血/再灌注损伤。我们旨在探讨 Dex 和 miR-146a 对缺氧/复氧(H/R)损伤心肌细胞的作用。

方法

用 H/R 损伤 H9C2 细胞。使用细胞计数试剂盒-8 检测细胞活力。使用商业试剂盒测定乳酸脱氢酶(LDH)活性、超氧化物歧化酶(SOD)活性和丙二醛(MDA)水平。通过流式细胞术测定细胞凋亡率和活性氧(ROS)水平。使用 Western blot 和 qPCR 评估蛋白和 mRNA 水平。

结果

在 H/R 损伤的情况下,miR-146a 的表达和 H9C2 细胞的活力降低。这种趋势可以通过 Dex 逆转,Dex 还可以上调 SOD 活性,降低 H9C2 细胞的凋亡率、LDH 活性、MDA、78-kDa 葡萄糖调节蛋白(GRP78)和 C/EBP 同源蛋白(CHOP)水平。miR-146a 负调节 GRP78 和 CHOP 水平。Dex 通过增加 miR-146a 的表达和下调 ROS、p38 磷酸化和细胞外信号调节激酶 1/2 水平来提高细胞活力、过氧化氢酶、MnSOD 和 NAD(P)H 脱氢酶(NQO1)水平,但抑制凋亡率、GRP78 和 CHOP 水平。通过使用 SB203580(SB),p38 丝裂原活化蛋白激酶(MAPK)抑制剂,Dex 或抑制 miR-146a 上调细胞活力,但下调 GRP78 和 CHOP 水平。

结论

Dex 可能调节 miR-146a 的表达,通过 MAPK 信号通路进一步调节内质网应激和氧化应激,最终影响 H/R 损伤心肌细胞的细胞活力和凋亡。

相似文献

1
Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.右美托咪定通过 MAPK 信号通路上调 miR-146a 表达减轻 H9C2 心肌细胞缺氧/复氧损伤。
Pharmacology. 2022;107(1-2):14-27. doi: 10.1159/000506814. Epub 2021 Oct 29.
2
Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.右美托咪定通过SIRT1/CHOP信号通路逆转缺氧/复氧损伤诱导的心肌细胞氧化应激和内质网应激依赖性凋亡。
Mol Cell Biochem. 2021 Jul;476(7):2803-2812. doi: 10.1007/s11010-021-04102-8. Epub 2021 Mar 16.
3
Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress.右美托咪定通过调控 p38MAPK 和内质网应激减轻 H9c2 心肌细胞的损伤和凋亡。
Drug Des Devel Ther. 2020 Oct 12;14:4231-4243. doi: 10.2147/DDDT.S265970. eCollection 2020.
4
Curcumin attenuates hypoxia/reoxygenation‑induced myocardial injury.姜黄素减轻低氧/复氧诱导的心肌损伤。
Mol Med Rep. 2019 Dec;20(6):4821-4830. doi: 10.3892/mmr.2019.10742. Epub 2019 Oct 15.
5
Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.右美托咪定通过抑制 NF-κB 通路靶向 IRAK1 和 TRAF6 的 miR-146a-3p 发挥心脏保护作用。
Biomed Pharmacother. 2021 Jan;133:110993. doi: 10.1016/j.biopha.2020.110993. Epub 2020 Nov 18.
6
Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway.右美托咪定通过调控 CHOP 信号通路对心肌细胞缺氧/复氧损伤的保护作用。
Mol Med Rep. 2020 Oct;22(4):3307-3315. doi: 10.3892/mmr.2020.11442. Epub 2020 Aug 19.
7
Resina draconis inhibits the endoplasmic-reticulum-induced apoptosis of myocardial cells via regulating miR-423-3p/ERK signaling pathway in a tree shrew myocardial ischemia- reperfusion model.龙血竭通过调控 miR-423-3p/ERK 信号通路抑制树鼩心肌缺血再灌注模型内质网诱导的心肌细胞凋亡。
J Biosci. 2019 Jun;44(2).
8
Dexmedetomidine protects against oxygen-glucose deprivation/reoxygenation injury-induced apoptosis via the p38 MAPK/ERK signalling pathway.右美托咪定通过p38丝裂原活化蛋白激酶/细胞外信号调节激酶信号通路保护细胞免受氧糖剥夺/复氧损伤诱导的细胞凋亡。
J Int Med Res. 2018 Feb;46(2):675-686. doi: 10.1177/0300060517734460. Epub 2017 Dec 6.
9
Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.右美托咪定通过 miR-208b-3p/Med13/Wnt 信号通路轴保护 H9C2 细胞对抗缺氧/复氧损伤。
Biomed Pharmacother. 2020 May;125:110001. doi: 10.1016/j.biopha.2020.110001. Epub 2020 Feb 25.
10
Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress.剂量为1微摩尔的右美托咪定通过抑制内质网应激,减轻缺氧暴露3小时和复氧3小时条件下H9c2心肌细胞的损伤。
Exp Ther Med. 2021 Feb;21(2):132. doi: 10.3892/etm.2020.9564. Epub 2020 Dec 10.

引用本文的文献

1
Targeting catalase in cancer.靶向肿瘤细胞中的过氧化氢酶。
Redox Biol. 2024 Nov;77:103404. doi: 10.1016/j.redox.2024.103404. Epub 2024 Oct 19.
2
Insight into Cardioprotective Effects and Mechanisms of Dexmedetomidine.右美托咪定的心脏保护作用及机制研究
Cardiovasc Drugs Ther. 2024 Dec;38(6):1139-1159. doi: 10.1007/s10557-024-07579-9. Epub 2024 Jun 13.
3
Plantamajoside alleviates hypoxia-reoxygenation injury through integrin-linked kinase/c-Src/Akt and the mitochondrial apoptosis signaling pathways in H9c2 myocardial cells.
大车前苷通过整合素连接激酶/c-Src/Akt和线粒体凋亡信号通路减轻H9c2心肌细胞缺氧复氧损伤。
BMC Complement Med Ther. 2023 Feb 24;23(1):64. doi: 10.1186/s12906-023-03880-6.
4
Dexmedetomidine Regulates the miR-146a-5p/NF-B Axis to Alleviate Electroconvulsive Therapy-Induced Cognitive Impairments.右美托咪定通过调控 miR-146a-5p/NF-κB 轴缓解电抽搐治疗引起的认知功能障碍。
Comput Math Methods Med. 2022 Oct 4;2022:8371492. doi: 10.1155/2022/8371492. eCollection 2022.
5
Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes.2型糖尿病性心肌病的表观遗传学研究进展
Front Cell Dev Biol. 2021 Dec 24;9:777258. doi: 10.3389/fcell.2021.777258. eCollection 2021.